Literature DB >> 1860861

A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base.

R A Poorman1, A G Tomasselli, R L Heinrikson, F J Kézdy.   

Abstract

Statistical analysis of an expanded data base of regions in viral polyproteins and in non-viral proteins that are sensitive to hydrolysis by the protease from human immunodeficiency virus (HIV) type 1 has generated a model which characterizes the substrate specificity of this retroviral enzyme. The model leads to an algorithm for predicting protease-susceptible sites from primary structure. Amino acids in each of the sites from P4 to P4' are tabulated for 40 protein substrates, and the frequency of occurrence for each residue is compared to the natural abundance of that amino acid in a selected data set of globular proteins. The results suggest that the highest stringency for particular amino acid residues is at the P2, P1, and P2' positions of the substrate. The broad specificity of the HIV-1 protease appears to be a consequence of its being able to bind productively substrates in which interactions with only a few Pi or Pi' side-chains need be optimized. The analysis, extended to 22 protein segments cleaved by the HIV-2 protease, delineates marked differences in specificity from that of the HIV-1 enzyme.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1860861

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Local and spatial factors determining HIV-1 protease substrate recognition.

Authors:  S Hazebrouck; V Machtelinckx-Delmas; J J Kupiec; P Sonigo
Journal:  Biochem J       Date:  2001-09-01       Impact factor: 3.857

2.  Mechanisms of the initiation of protein synthesis: in reading frame binding of ribosomes to mRNA.

Authors:  Tokumasa Nakamoto
Journal:  Mol Biol Rep       Date:  2010-05-14       Impact factor: 2.316

3.  Predicting human immunodeficiency virus protease cleavage sites in nonlinear projection space.

Authors:  Xuehua Li; Hongli Hu; Lan Shu
Journal:  Mol Cell Biochem       Date:  2010-01-07       Impact factor: 3.396

4.  Coevolutionary analysis of resistance-evading peptidomimetic inhibitors of HIV-1 protease.

Authors:  C D Rosin; R K Belew; G M Morris; A J Olson; D S Goodsell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

5.  A sequence-coupled vector-projection model for predicting the specificity of GalNAc-transferase.

Authors:  K C Chou
Journal:  Protein Sci       Date:  1995-07       Impact factor: 6.725

6.  Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.

Authors:  K Wiegers; G Rutter; H Kottler; U Tessmer; H Hohenberg; H G Kräusslich
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus.

Authors:  G Schatz; I Pichova; V M Vogt
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease.

Authors:  Steve C Pettit; Gavin J Henderson; Celia A Schiffer; Ronald Swanstrom
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Drug resistance in HIV-1 protease: Flexibility-assisted mechanism of compensatory mutations.

Authors:  Stefano Piana; Paolo Carloni; Ursula Rothlisberger
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

10.  The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.

Authors:  S C Pettit; M D Moody; R S Wehbie; A H Kaplan; P V Nantermet; C A Klein; R Swanstrom
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.